Insights Into Candidiasis: Global Clinical Research Overview

Candidiasis, caused by Candida, is a global health concern with varying prevalence rates worldwide. Social determinants and socioeconomic factors influence the susceptibility of certain populations, such as Black and African American individuals in the U.S. and Chinese and African populations. The emergence of drug-resistant Candida strains poses challenges to standard treatments, but recent advancements in treatment offer hope for improved outcomes. Clinical trials for Candidiasis are primarily conducted in the Asia-Pacific region, particularly in Mainland China, with contributions from North America and Europe.

Explore how ongoing research in vaccine development and novel drug classes is showing promise in addressing Candidiasis.